You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 1, January 13, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (48)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Obesity
 •Hypertension
 •Review
 •Lipids and Lipid Disorders
 •Alert me on articles by topic

Cardiovascular Disease in Type 2 Diabetes Mellitus

Current Management Guidelines

Arshag D. Mooradian, MD

Arch Intern Med. 2003;163:33-40.

Cardiovascular disease is the most prevalent and detrimental complication of diabetes mellitus. The incidence of cardiovascular mortality in diabetic subjects without a clinical history of previous cardiac events is as high as the incidence in nondiabetic subjects with a history of myocardial infarction. This inordinate increase in the risk of coronary events in diabetic patients is attributed to multiple factors, including glycation and oxidation of proteins and increased prevalence of classic risk factors of coronary disease, such as hypertension, obesity, and dyslipidemia. Despite advances in the management of cardiovascular disease, a large proportion of diabetic subjects continue to have uncontrolled hyperglycemia, hypertension, and dyslipidemia. In addition, certain medical interventions with established efficacy in the general population do not appear to be appropriate for diabetic subjects. Recently published clinical trials of managing coronary risk factors indicate that more stringent goals of therapy should be set for diabetic patients. In this communication, some of these landmark studies are reviewed and some practical guidelines of management are suggested.


From the Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, St Louis University School of Medicine, St Louis, Mo.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diabetes, the Metabolic Syndrome, and Ischemic Stroke: Epidemiology and possible mechanisms
Air and Kissela
Diabetes Care 2007;30:3131-3140.
FULL TEXT  

The Effect of Glucosamine on Serum HDL Cholesterol and Apolipoprotein AI Levels in People With Diabetes
Albert et al.
Diabetes Care 2007;30:2800-2803.
ABSTRACT | FULL TEXT  

Propagation of the cardiac impulse in the diabetic rat heart: reduced conduction reserve
Nygren et al.
J. Physiol. 2007;580:543-560.
ABSTRACT | FULL TEXT  

Pharmacist membership in a medical group's diabetes health management program
Brooks et al.
Am J Health Syst Pharm 2007;64:617-621.
ABSTRACT | FULL TEXT  

Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction
Benter et al.
Am. J. Physiol. Heart Circ. Physiol. 2007;292:H666-H672.
ABSTRACT | FULL TEXT  

Differential autocrine modulation of atrial and ventricular potassium currents and of oxidative stress in diabetic rats
Shimoni et al.
Am. J. Physiol. Heart Circ. Physiol. 2006;290:H1879-H1888.
ABSTRACT | FULL TEXT  

The Effect of Select Nutrients on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels
Mooradian et al.
Endocr. Rev. 2006;27:2-16.
ABSTRACT | FULL TEXT  

Synergistic Acceleration of Arterial Stiffening in the Presence of Raised Blood Pressure and Raised Plasma Glucose
Tomiyama et al.
Hypertension 2006;47:180-188.
ABSTRACT | FULL TEXT  

Can diabetes management programs create sustained improvements in disease outcomes?
Rothman and Elasy
CMAJ 2005;173:1467-1468.
FULL TEXT  

Oxidative Stress and Antioxidant Treatment in Diabetes
SCOTT and KING
Ann. N. Y. Acad. Sci. 2004;1031:204-213.
ABSTRACT | FULL TEXT  

Alcohol Use and Diabetes Mellitus
Mascitelli and Pezzetta
ANN INTERN MED 2004;141:409-409.
FULL TEXT  

Update in Renal Transplantation
Magee and Pascual
Arch Intern Med 2004;164:1373-1388.
ABSTRACT | FULL TEXT  

Gender differences in ANG II levels and action on multiple K+ current modulation pathways in diabetic rats
Shimoni and Liu
Am. J. Physiol. Heart Circ. Physiol. 2004;287:H311-H319.
ABSTRACT | FULL TEXT  

Mortality and Predictors of Mortality in a Cohort of Brazilian Type 2 Diabetic Patients
Salles et al.
Diabetes Care 2004;27:1299-1305.
ABSTRACT | FULL TEXT  

Transcriptional Control of Apolipoprotein A-I Gene Expression in Diabetes
Mooradian et al.
Diabetes 2004;53:513-520.
ABSTRACT | FULL TEXT  

Dietary L-Arginine Supplementation Enhances Endothelial Nitric Oxide Synthesis in Streptozotocin-Induced Diabetic Rats
Kohli et al.
J. Nutr. 2004;134:600-608.
ABSTRACT | FULL TEXT  

Oxidative Stress: The Lead or Supporting Actor in the Pathogenesis of Diabetic Complications
Kuroki et al.
J. Am. Soc. Nephrol. 2003;14:S216-220.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.